SoP Library › Microscopic polyangiitis

Statement of Principles

Microscopic polyangiitis — DVA SoP factors

Every factor in the Repatriation Medical Authority Statements of Principles for Microscopic polyangiitis. DVA can only accept a claim for Microscopic polyangiitis if at least one of these factors is met and connected to your service. Reasonable Hypothesis (RH) applies to operational service; Balance of Probabilities (BoP) applies to peacetime service.

Source: Repatriation Medical Authority Statements of Principles as held by the Veterans Health Centre. SoPs are amended and replaced regularly; always confirm the current instrument at rma.gov.au before relying on it.

Microscopic polyangiitis

RH No. 90 of 2019 · BoP No. 91 of 201914 factors

Meaning of microscopic polyangiitis: For the purposes of this Statement of Principles, microscopic polyangiitis: (a) means a necrotising non-granulomatous vasculitis with few or no immune deposits predominantly affecting small vessels (capillaries, venules or arterioles); and (b) excludes polyarteritis nodosa, granulomatosis with polyangiitis (Wegener granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Reasonable Hypothesis (RH) — Statement of Principles No. 90 of 2019

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting microscopic polyangiitis or death from microscopic polyangiitis with the circumstances of a person's relevant service:

  1. (1)
    inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being: (a) produced; (b) excavated; (c) drilled, cut or ground; or (d) used in construction, manufacturing, cleaning or blasting; for a cumulative period of at least 2 500 hours before the clinical onset of microscopic polyangiitis;
  2. (2)
    having silicosis at the time of the clinical onset of microscopic polyangiitis;
  3. (3)
    being treated with a drug from the specified list of drugs at the time of the clinical onset of microscopic polyangiitis;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  4. (4)
    inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being: (a) produced; (b) excavated; (c) drilled, cut or ground; or (d) used in construction, manufacturing, cleaning or blasting; for a cumulative period of at least 2 500 hours before the clinical worsening of microscopic polyangiitis;
  5. (5)
    having silicosis at the time of the clinical worsening of microscopic polyangiitis;
  6. (6)
    being treated with a drug from the specified list of drugs at the time of the clinical worsening of microscopic polyangiitis;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  7. (7)
    inability to obtain appropriate clinical management for microscopic polyangiitis;

Aggravation-only factors: the factors in subsections 9(4) to 9(7) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

Balance of Probabilities (BoP) — Statement of Principles No. 91 of 2019

7 factors

At least one of the following factors must exist before it can be said that, on the balance of probabilities, microscopic polyangiitis or death from microscopic polyangiitis is connected with the circumstances of a person's relevant service:

  1. (1)
    inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being: (a) produced; (b) excavated; (c) drilled, cut or ground; or (d) used in construction, manufacturing, cleaning or blasting; for a cumulative period of at least 5 000 hours before the clinical onset of microscopic polyangiitis;
  2. (2)
    having silicosis at the time of the clinical onset of microscopic polyangiitis;
  3. (3)
    being treated with a drug from the specified list of drugs at the time of the clinical onset of microscopic polyangiitis;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  4. (4)
    inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being: (a) produced; (b) excavated; (c) drilled, cut or ground; or (d) used in construction, manufacturing, cleaning or blasting; for a cumulative period of at least 5 000 hours before the clinical worsening of microscopic polyangiitis;
  5. (5)
    having silicosis at the time of the clinical worsening of microscopic polyangiitis;
  6. (6)
    being treated with a drug from the specified list of drugs at the time of the clinical worsening of microscopic polyangiitis;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  7. (7)
    inability to obtain appropriate clinical management for microscopic polyangiitis;

Aggravation-only factors: the factors in subsection 9(4) to 9(7) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

A VHC Diagnostic Assessment addresses each of these factors one by one against your service record and clinical history. See how a VHC DVA claim works, see all fees ($600 + GST per stage) or book an appointment.

Accepted — what is it worth?

A Statement of Principles decides one thing only: whether DVA accepts liability for microscopic polyangiitis. It says nothing about how much you are paid. Compensation is worked out separately, from impairment points under the GARP — so a condition can be accepted and still rate few points, or rate more than you expect once it is combined with everything else on your file.

Part of DVA Claims — Blood & immune system — every Statement of Principles covering the blood and immune system.

Others in this area:

Dr Thomas Perkins, Veterans Health Centre

Reviewed by Dr Thomas Perkins

Founding doctor, Veterans Health Centre · former RAAF aviation medical officer · 13 years working exclusively with ADF members and veterans. Full profile →